Orange Book product · Generic (ANDA)
PYRIDOSTIGMINE BROMIDE
PYRIDOSTIGMINE BROMIDE
At a glance
Sep 21, 2023
Approved
Generic (ANDA)
Application
AA
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 21, 2023
2 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
PYRIDOSTIGMINE BROMIDE
Strength
60MG/5ML
Dosage form
SYRUP
Route
ORAL
TE code
AA
Application
ANDA 216512
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PYRIDOSTIGMINE BROMIDE
- 2024PYRIDOSTIGMINE BROMIDEBrand (NDA)
NDA 217604 · AMNEAL
- 2003PYRIDOSTIGMINE BROMIDEBrand (NDA)
NDA 020414 · US ARMY
- —MESTINONBrand (NDA)
NDA 009830 · BAUSCH
- —REGONOLBrand (NDA)
NDA 017398 · SANDOZ
- —MESTINONBrand (NDA)
NDA 015193 · BAUSCH
- —MESTINONBrand (NDA)
NDA 011665 · BAUSCH
- —MESTINONBrand (NDA)
NDA 009829 · BAUSCH
- 2022PYRIDOSTIGMINE BROMIDEGeneric (ANDA)
ANDA 040502 · IMPAX LABS
- 2022PYRIDOSTIGMINE BROMIDEGeneric (ANDA)
ANDA 212405 · MILLA PHARMS
- 2020PYRIDOSTIGMINE BROMIDEGeneric (ANDA)
ANDA 212702 · AMNEAL
- 2020PYRIDOSTIGMINE BROMIDEGeneric (ANDA)
ANDA 208797 · RISING
- 2019PYRIDOSTIGMINE BROMIDEGeneric (ANDA)
ANDA 211181 · MLV
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
